Hundreds of people prayed for the victims of Minamata disease in a ceremony in southwestern Japan on Thursday, 69 years after the neurological disorder caused by polluted industrial wastewater was ...

Japanese Environment Minister Asao Keiichiro has begun discussions with groups of Minamata disease sufferers on the eve of a memorial service for victims of the pollution-induced illness.

Omega-3s can lower triglycerides, reduce blood pressure, and decrease the risk of heart disease. So, if you cannot get these fatty fish in your daily diet, the best way to compensate is fish oil ...

While initial testing of scores of dead fish, said to be pilchards, on Hobart beaches returned positive results for a pilchard virus, experts are reluctant to draw conclusions about what caused ...

by KOMO News Staff TOPICS: WASHINGTON STATE — It is now illegal to feed deer, elk, and moose in Washington, per a rule approved by the director of the Washington Department of Fish and Wildlife ...

In September 2024, the landscape in the Middle Solimões region of the Brazilian Amazon lay in stark contrast to its usual ...

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of cardiovascular disease. In a new study, led by Chalmers University of ...

Fish oil made from fatty fish is known as krill oil. Some studies have shown that krill oil may be better absorbed by the body and more effective at improving risk factors for heart disease.

Fatty fish also boast omega-3 fatty acids, which are crucial for optimal body and brain function and strongly linked to a reduced risk of many diseases. To meet your omega-3 requirements ...

In Senegal's gold-rich Kedougou region, the widespread use of mercury in artisanal mining poses severe health and environmental risks, particularly for women and children. Despite government ...

Phthalate exposure from plastics and cardiovascular disease: global estimates of attributable mortality and years life lost. eBioMedicine , 2025; 105730 DOI: 10.1016/j.ebiom.2025.105730 Cite This ...

An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been delayed—again—this time, with no new decision date given. The biotech ...